Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8846710 Method of preferentially inducing the biosynthesis of interferon

Patent 8846710 was granted and assigned to 3M on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88467100

Patent Inventor Names

Bryon A. Merrill0

Gregory D. Lundquist, Jr.0

Gregory J. Marszalek0

Joshua R. Wurst0

Karl J. Manske0

Kyle J. Lindstrom0

Michael E. Danielson0

Philip D. Heppner0

...

Date of Patent

September 30, 2014

Patent Application Number

118849820

Date Filed

February 22, 2006

Patent Citations Received

‌

US Patent 12077539 Imidazole and triazole KRAS inhibitors

‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

‌

US Patent 11939328 Quinoline compounds as inhibitors of KRAS

‌

US Patent 11999752 Vinyl imidazole compounds as inhibitors of KRAS

Patent Primary Examiner

‌

Savitha Rao

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846710 Method of preferentially inducing the biosynthesis of interferon

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API